Edwards Lifesciences Corporation Share-based Payment Arrangement, Expense
Edwards Lifesciences Corporation (EW) reported Share-based Payment Arrangement, Expense of $42.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-04
- Edwards Lifesciences Corporation share-based payment arrangement, expense for the quarter ending 2026-06-30 was $42.20M, a 12.53% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for the quarter ending 2026-03-31 was $45.40M, a 13.22% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for the quarter ending 2025-12-31 was $39.20M, a 14.96% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for the quarter ending 2025-09-30 was $41.10M, a 16.76% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for fiscal 2025 was $157.90M, a 8.45% increase from fiscal 2024.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for fiscal 2024 was $145.60M, a 16.67% increase from fiscal 2023.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for fiscal 2023 was $124.80M, a 9.86% increase from fiscal 2022.
- Edwards Lifesciences Corporation share-based payment arrangement, expense for fiscal 2022 was $113.60M, a 3.93% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $42.20M 10-Q · filed 2026-08-04 | $87.60M 10-Q · filed 2026-08-04 | $126.80M derived: sum of 3 quarters · filed 2026-08-04 | $167.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $45.40M 10-Q · filed 2026-05-06 | $84.60M derived: sum of 2 quarters · filed 2026-05-06 | $125.70M derived: sum of 3 quarters · filed 2026-05-06 | $163.20M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $39.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $80.30M derived: sum of 2 quarters · filed 2026-02-25 | $117.80M derived: sum of 3 quarters · filed 2026-08-04 | $157.90M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $41.10M 10-Q · filed 2025-11-05 | $78.60M derived: sum of 2 quarters · filed 2026-08-04 | $118.70M 10-Q · filed 2025-11-05 | $152.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $37.50M 10-Q · filed 2026-08-04 | $77.60M 10-Q · filed 2026-08-04 | $111.70M derived: sum of 3 quarters · filed 2026-08-04 | $146.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $40.10M 10-Q · filed 2026-05-06 | $74.20M derived: sum of 2 quarters · filed 2026-05-06 | $109.40M derived: sum of 3 quarters · filed 2026-05-06 | $146.70M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $34.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $69.30M derived: sum of 2 quarters · filed 2026-02-25 | $106.60M derived: sum of 3 quarters · filed 2026-02-25 | $145.60M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $35.20M 10-Q · filed 2025-11-05 | $72.50M derived: sum of 2 quarters · filed 2025-11-05 | $111.50M 10-Q · filed 2025-11-05 | $139.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $37.30M 10-Q · filed 2025-08-06 | $37.50M 10-Q · filed 2024-07-31 | $76.30M 10-Q · filed 2025-08-06 | $76.50M 10-Q · filed 2024-07-31 | $103.80M derived: sum of 3 quarters · filed 2026-02-25 | $132.90M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $39.00M 10-Q · filed 2025-05-06 | $44.60M 10-Q · filed 2024-04-29 | $66.50M derived: sum of 2 quarters · filed 2026-02-25 | $95.60M derived: sum of 3 quarters · filed 2026-02-25 | $129.30M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $56.60M derived: sum of 2 quarters · filed 2026-02-25 | $90.30M derived: sum of 3 quarters · filed 2026-02-25 | $124.80M 10-K · filed 2026-02-25 | $139.40M 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $29.10M 10-Q · filed 2024-11-06 | $32.60M 10-Q · filed 2023-10-27 | $62.80M derived: sum of 2 quarters · filed 2024-11-06 | $97.30M 10-Q · filed 2024-11-06 | $108.90M 10-Q · filed 2023-10-27 | $116.40M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $33.70M 10-Q · filed 2024-07-31 | $37.40M 10-Q · filed 2023-07-28 | $68.50M 10-Q · filed 2024-07-31 | $76.30M 10-Q · filed 2023-07-28 | $87.30M derived: sum of 3 quarters · filed 2025-02-28 | $117.60M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $38.90M 10-Q · filed 2024-04-29 | $53.60M derived: sum of 2 quarters · filed 2025-02-28 | $83.90M derived: sum of 3 quarters · filed 2025-02-28 | $120.10M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $45.00M derived: sum of 2 quarters · filed 2025-02-28 | $81.20M derived: sum of 3 quarters · filed 2025-02-28 | $113.60M 10-K · filed 2025-02-28 | $126.80M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $30.30M 10-Q · filed 2023-10-27 | $66.50M derived: sum of 2 quarters · filed 2023-10-27 | $98.90M 10-Q · filed 2023-10-27 | $123.10M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $36.20M 10-Q · filed 2023-07-28 | $68.60M 10-Q · filed 2023-07-28 | $92.80M derived: sum of 3 quarters · filed 2024-02-12 | $119.40M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $32.40M 10-Q · filed 2023-04-28 | $56.60M derived: sum of 2 quarters · filed 2024-02-12 | $83.20M derived: sum of 3 quarters · filed 2024-02-12 | $113.50M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $50.80M derived: sum of 2 quarters · filed 2024-02-12 | $81.10M derived: sum of 3 quarters · filed 2024-02-12 | $109.30M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $26.60M 10-Q · filed 2022-10-28 | $56.90M derived: sum of 2 quarters · filed 2022-10-28 | $85.10M 10-Q · filed 2022-10-28 | $106.00M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $30.30M 10-Q · filed 2022-07-29 | $58.50M 10-Q · filed 2022-07-29 | $79.40M derived: sum of 3 quarters · filed 2023-02-13 | $102.40M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $28.20M 10-Q · filed 2022-04-28 | $49.10M derived: sum of 2 quarters · filed 2023-02-13 | $72.10M derived: sum of 3 quarters · filed 2023-02-13 | $96.90M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $20.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $43.90M derived: sum of 2 quarters · filed 2023-02-13 | $68.70M derived: sum of 3 quarters · filed 2023-02-13 | $92.60M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $23.00M 10-Q · filed 2021-10-29 | $47.80M derived: sum of 2 quarters · filed 2021-10-29 | $71.70M 10-Q · filed 2021-10-29 | $90.10M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-06-30 | $24.80M 10-Q · filed 2021-07-30 | $48.70M 10-Q · filed 2021-07-30 | $67.10M derived: sum of 3 quarters · filed 2022-02-14 | $86.90M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-03-31 | $23.90M 10-Q · filed 2021-04-28 | $42.30M derived: sum of 2 quarters · filed 2022-02-14 | $62.10M derived: sum of 3 quarters · filed 2022-02-14 | $84.40M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2019-12-31 | $18.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14 | $38.20M derived: sum of 2 quarters · filed 2022-02-14 | $60.50M derived: sum of 3 quarters · filed 2022-02-14 | $81.30M 10-K · filed 2022-02-14 | ||||
| 2019-09-30 | $19.80M 10-Q · filed 2020-10-26 | $42.10M derived: sum of 2 quarters · filed 2020-10-26 | $62.90M 10-Q · filed 2020-10-26 | $78.90M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | $22.30M 10-Q · filed 2020-07-27 | $43.10M 10-Q · filed 2020-07-27 | $59.10M derived: sum of 3 quarters · filed 2021-02-12 | $76.50M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | $20.80M 10-Q · filed 2020-04-28 | $36.80M derived: sum of 2 quarters · filed 2021-02-12 | $54.20M derived: sum of 3 quarters · filed 2021-02-12 | $73.40M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $33.40M derived: sum of 2 quarters · filed 2021-02-12 | $52.60M derived: sum of 3 quarters · filed 2021-02-12 | $71.00M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | $17.40M 10-Q · filed 2019-10-25 | $36.60M derived: sum of 2 quarters · filed 2019-10-25 | $55.00M 10-Q · filed 2019-10-25 | $71.10M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $19.20M 10-Q · filed 2018-07-27 | $37.60M 10-Q · filed 2019-07-26 | $53.70M derived: sum of 3 quarters · filed 2020-02-14 | $69.50M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | $19.20M 10-Q · filed 2019-07-26 | $18.40M 10-Q · filed 2018-04-27 | $34.50M derived: sum of 2 quarters · filed 2020-02-14 | $50.30M derived: sum of 3 quarters · filed 2020-02-14 | $65.60M derived: sum of 4 quarters · filed 2020-02-14 | |||
| 2017-12-31 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $31.10M derived: sum of 2 quarters · filed 2020-02-14 | $46.40M derived: sum of 3 quarters · filed 2020-02-14 | $61.60M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $15.80M 10-Q · filed 2018-10-26 | $31.10M derived: sum of 2 quarters · filed 2018-10-26 | $46.30M 10-Q · filed 2018-10-26 | $60.20M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | $15.30M 10-Q · filed 2018-07-27 | $30.50M 10-Q · filed 2018-07-27 | $44.40M derived: sum of 3 quarters · filed 2019-02-15 | $58.80M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | $15.20M 10-Q · filed 2018-04-27 | $29.10M derived: sum of 2 quarters · filed 2019-02-15 | $43.50M derived: sum of 3 quarters · filed 2019-02-15 | $57.80M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $28.30M derived: sum of 2 quarters · filed 2019-02-15 | $42.60M derived: sum of 3 quarters · filed 2019-02-15 | $56.90M 10-K · filed 2019-02-15 | ||||
| 2016-09-30 | $14.40M 10-Q · filed 2017-10-27 | $28.70M derived: sum of 2 quarters · filed 2017-10-27 | $43.00M 10-Q · filed 2017-10-27 | $55.90M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $14.30M 10-Q · filed 2017-07-28 | $28.60M 10-Q · filed 2017-07-28 | $41.50M derived: sum of 3 quarters · filed 2018-02-16 | $54.10M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $14.30M 10-Q · filed 2017-04-28 | $27.20M derived: sum of 2 quarters · filed 2018-02-16 | $39.80M derived: sum of 3 quarters · filed 2018-02-16 | $50.60M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $25.50M derived: sum of 2 quarters · filed 2018-02-16 | $36.30M derived: sum of 3 quarters · filed 2018-02-16 | $49.90M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $12.60M 10-Q · filed 2016-10-28 | $23.40M derived: sum of 2 quarters · filed 2016-10-28 | $37.00M 10-Q · filed 2016-10-28 | $49.20M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $10.80M 10-Q · filed 2016-07-29 | $24.40M 10-Q · filed 2016-07-29 | $36.60M derived: sum of 3 quarters · filed 2017-02-17 | $48.80M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $13.60M 10-Q · filed 2016-04-29 | $25.80M derived: sum of 2 quarters · filed 2017-02-17 | $38.00M derived: sum of 3 quarters · filed 2017-02-17 | $49.90M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $24.40M derived: sum of 2 quarters · filed 2017-02-17 | $36.30M derived: sum of 3 quarters · filed 2017-02-17 | $48.30M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $12.20M 10-Q · filed 2015-10-29 | $24.10M derived: sum of 2 quarters · filed 2015-10-29 | $36.10M 10-Q · filed 2015-10-29 | $47.60M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $11.90M 10-Q · filed 2015-07-29 | $23.90M 10-Q · filed 2015-07-29 | $35.40M derived: sum of 3 quarters · filed 2016-02-19 | $47.30M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $12.00M 10-Q · filed 2015-04-29 | $23.50M derived: sum of 2 quarters · filed 2016-02-19 | $35.40M derived: sum of 3 quarters · filed 2016-02-19 | $48.20M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $23.40M derived: sum of 2 quarters · filed 2016-02-19 | $36.20M derived: sum of 3 quarters · filed 2016-02-19 | $47.40M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $11.90M 10-Q · filed 2014-10-31 | $24.70M derived: sum of 2 quarters · filed 2014-10-31 | $35.90M 10-Q · filed 2014-10-31 | $46.70M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $12.80M 10-Q · filed 2014-08-04 | $24.00M 10-Q · filed 2014-08-04 | $34.80M derived: sum of 3 quarters · filed 2015-02-20 | $45.70M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-03-31 | $11.20M 10-Q · filed 2014-05-02 | $22.00M derived: sum of 2 quarters · filed 2015-02-20 | $32.90M derived: sum of 3 quarters · filed 2015-02-20 | $44.10M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2012-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $21.70M derived: sum of 2 quarters · filed 2015-02-20 | $32.90M derived: sum of 3 quarters · filed 2015-02-20 | $42.10M 10-K · filed 2015-02-20 | ||||
| 2012-09-30 | $10.90M 10-Q · filed 2013-11-07 | $22.10M derived: sum of 2 quarters · filed 2013-11-07 | $31.30M 10-Q · filed 2013-11-07 | $40.30M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $11.20M 10-Q · filed 2013-08-06 | $20.40M 10-Q · filed 2013-08-06 | $29.40M derived: sum of 3 quarters · filed 2014-02-28 | $39.90M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $9.20M 10-Q · filed 2013-05-06 | $18.20M derived: sum of 2 quarters · filed 2014-02-28 | $28.70M derived: sum of 3 quarters · filed 2014-02-28 | $36.50M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $19.50M derived: sum of 2 quarters · filed 2014-02-28 | $27.30M derived: sum of 3 quarters · filed 2014-02-28 | $35.00M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $10.50M 10-Q · filed 2012-11-07 | $18.30M derived: sum of 2 quarters · filed 2012-11-07 | $26.00M 10-Q · filed 2012-11-07 | $32.90M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $7.80M 10-Q · filed 2012-08-07 | $15.50M 10-Q · filed 2012-08-07 | $22.40M derived: sum of 3 quarters · filed 2013-02-28 | $31.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $7.70M 10-Q · filed 2012-05-09 | $14.60M derived: sum of 2 quarters · filed 2013-02-28 | $23.20M derived: sum of 3 quarters · filed 2013-02-28 | $29.50M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $15.50M derived: sum of 2 quarters · filed 2013-02-28 | $21.80M derived: sum of 3 quarters · filed 2013-02-28 | $29.30M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $8.60M 10-Q · filed 2011-11-08 | $14.90M derived: sum of 2 quarters · filed 2011-11-08 | $22.40M 10-Q · filed 2011-11-08 | |||||
| 2010-06-30 | $6.30M 10-Q · filed 2011-08-08 | $13.80M 10-Q · filed 2011-08-08 | ||||||
| 2010-03-31 | $7.50M 10-Q · filed 2011-05-09 | |||||||
| 2009-12-31 | $28.30M 10-K · filed 2012-02-27 | |||||||
| 2008-12-31 | $28.70M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |